Table 1.
Distribution of various prognostic factors and deaths from thyroid cancer in different age groups. HCTC, Hürthle cell thyroid carcinoma.
| Age (years) | Males (%) | T3/T4 tumor (%) | HCTC (%) | Distant metastasis (%) | Incomplete resection (%) | Case fatality rate |
|---|---|---|---|---|---|---|
| 00–19 (n=84) | 16.7 | 34.6 | 2.4 | 0 | 0 | 0 (0%) |
| 20–29 (n=268) | 19.0 | 21.5 | 0 | 0.7 | 2.4 | 1 (0.4%) |
| 30–39 (n=413) | 19.6 | 25.1 | 2.4 | 0.7 | 1.0 | 4 (1.0%) |
| 40–44 (n=202) | 21.3 | 19.7 | 4.5 | 1.5 | 1.6 | 4 (2.0%) |
| 45–49 (n=212) | 20.3 | 19.0 | 2.8 | 1.9 | 2.5 | 6 (2.8%) |
| 50–54 (n=192) | 22.9 | 23.6 | 5.7 | 0 | 1.7 | 3 (1.6%) |
| 55–59 (n=193) | 30.6 | 33.1 | 5.7 | 1.6 | 3.0 | 13 (6.7%) |
| 60–64 (n=179) | 30.7 | 34.0 | 6.1 | 4.5 | 5.1 | 12 (6.7%) |
| 65–69 (n=133) | 28.6 | 35.2 | 4.5 | 5.3 | 4.6 | 16 (12.0%) |
| 70–74 (n=98) | 32.7 | 32.5 | 6.1 | 8.2 | 8.4 | 15 (15.3%) |
| 75–79 (n=73) | 24.7 | 41.7 | 9.6 | 5.5 | 10.3 | 11 (15.1%) |
| 80–89 (n=68) | 23.5 | 53.8 | 8.8 | 17.6 | 14.0 | 20 (29.4%) |